TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
EDSA

Edesa Biotech Inc

Healthcare · Biotechnology

4.20$ +18.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow EDSA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– +0.8% -6.2% +19.9% +5.0% -97.5% +1,104.5% +106.4% -0.5% +55.2% +1.4% -35.9%
– -72.1% -2.9% -55.5% +33.6% -69.9% +1,186.6% +434.0% -29.3% -44.9% -56.9% +35.7%
– – – – -45.6% -42.8% +1,186.6% +434.0% -29.3% – – –
– -349.2% – – -93.4% -16,270.1% – -603.6% – -89.3% +85.4% -272.6%
– -1.6% +46.5% -24.7% +26.5% -97.9% +324.2% -82.1% -8.0% -99.9% -100.0% –
– – +355.1% +203.5% -364.0% – -99.7% -132.2% -8.0% – – –
– – +7,060.3% – – – – – – – – –
– – – – -93.3% +0.0% +0.0% -100.0% – – – -100.0%
– -99.0% +6,748.8% -99.9% +148,306.4% -19.1% +0.0% +99.8% -18.0% -58.5% -87.7% +2,776.7%
– -186.4% – -182.2% – – +31.2% -71.3% -219.6% – – –
– – – – – – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?